Stay updated on Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision: v3.6.5 has been added to the page history, replacing the previous v3.6.4. This represents a metadata update to the page rather than any substantive changes to study information.
    Difference
    0.0%
    Check dated 2026-08-13T01:55:10.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The history section now shows Revision: v3.6.4, replacing Revision: v3.6.3, reflecting a new version of the study record history.
    Difference
    0.0%
    Check dated 2026-07-22T09:54:28.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study history now shows the latest Revision: v3.6.3, replacing the previous Revision: v3.6.0.
    Difference
    0.0%
    Check dated 2026-07-01T02:46:55.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The study record now shows recruitment is closed, indicating enrollment has ended. The revision history is updated with a new 'Revision: v3.6.0' entry and the previous 'Revision: v3.5.5' entry is removed.
    Difference
    0.1%
    Check dated 2026-06-16T16:24:22.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The history now includes a new revision entry, v3.5.5, following the previous v3.5.4, representing an updated version of the page history.
    Difference
    0.0%
    Check dated 2026-06-08T14:57:55.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.3 to v3.5.4, indicating a new release/patch was applied. This update relates to site metadata rather than changes to study data or visible content.
    Difference
    0.0%
    Check dated 2026-05-18T03:46:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Lenvatinib vs Docetaxel in NSCLC Clinical Trial page.